Related Experiment Video
Updated: May 18, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
[Eye complications in type 2 diabetes mellitus]
1Øjenafdelingen, Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C, Denmark. toke.bek@mail.tele.dk
Ugeskrift for Laeger
|September 14, 2012
Summary
Diabetic retinopathy, a leading cause of blindness in type 2 diabetes, can be managed with early screening and new treatments. Intravitreal angiostatic therapy offers an effective alternative to traditional retinal photocoagulation.
Area of Science:
- Ophthalmology
- Endocrinology
- Diabetology
Context:
- Diabetic retinopathy is a major cause of blindness, particularly in individuals with type 2 diabetes mellitus (T2D).
- Systematic screening programs and risk-factor-based decision models enhance visual prognosis.
- Traditional retinal photocoagulation for diabetic retinopathy carries significant adverse effects for T2D patients.
Purpose:
- To highlight the challenges in managing diabetic retinopathy in T2D.
- To introduce advancements in screening and treatment modalities.
- To present intravitreal angiostatic therapy as a novel treatment option.
Summary:
- Diabetic retinopathy poses a significant threat to vision, especially in type 2 diabetes.
- Early detection through systematic screening and individualized risk assessment improves outcomes.
- Intravitreal angiostatic therapy emerges as a promising alternative to conventional photocoagulation, mitigating adverse effects.
Impact:
- Improved visual outcomes for diabetic retinopathy patients through enhanced screening strategies.
- Reduced adverse effects associated with diabetic retinopathy treatment.
- Potential for better long-term vision preservation with novel intravitreal angiostatic therapies.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...